HIV infection worsens age-associated defects in antibody responses to influenza vaccine

Journal of Infectious Diseases

Volumn 211, Issue 12, 2015, Pages 1959-1968

  George, Varghese K ^a   Pallikkuth, Suresh ^a   Parmigiani, Anita ^a,d   Alcaide, Maria ^b   Fischl, Margaret ^c   Arheart, Kristopher L ^a   Pahwa, Savita ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Division of Infectious Diseases   (United States)

^c AIDS Clinical Research Unit Department of Medicine   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

aging; CD4 T cell immune activation; HIV infection; IL 21; inflammation; memory B cells; peripheral T follicular helper cells; seasonal influenza vaccination

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE; INTERLEUKIN 21; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY;

ADULT; AGE; AGED; AGING; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SECRETING CELL; ANTIBODY TITER; ARTICLE; BLOOD SAFETY; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DRUG RESPONSE; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; LYMPHOCYTE FUNCTION; MEMORY CELL; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL T FOLLICULAR HELPER CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE DRUG DOSE; T LYMPHOCYTE; B LYMPHOCYTE; IMMUNOLOGY; INFLUENZA, HUMAN; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODY FORMATION; B-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84930369710     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu840     Document Type: Article

References (47)

1. High KP, Brennan-Ing M, Clifford DB, et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 2012; 60(suppl 1):S1-18.
2. Health Protection Agency UK. HIV in the United Kingdom: 2011 report. http://www.ivecic.com/uploads/7/5/4/1/7541913/hiv-in-the-uk-2011-report.pdf. Accessed 14 August 2014.
3. Lambert ND, Ovsyannikova IG, Pankratz VS, Jacobson RM, Poland GA. Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Expert Rev Vaccines 2012; 11:985-94.
4. Malaspina A, Moir S, Orsega SM, et al. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis 2005; 191:1442-50.
5. Parmigiani A, Alcaide ML, Freguja R, et al. Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation. PLoS One 2013; 8: e79816.
6. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011; 62:141-55.
7. Center for Disease Control and Prevention. People at high-risk of developing flu-like complications. http://www.cdc.gov/flu/about/disease/ high-risk.htm. Accessed 14 August 2014.
8. Sheth AN, Althoff KN, Brooks JT. Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature. Clin Infect Dis 2011; 52:219-27.
9. Glezen WP, Simonsen L. Commentary: benefits of influenza vaccine in US elderly-new studies raise questions. Int J Epidemiol 2006; 35:352-3.
10. Jenny NS. Inflammation in aging: cause, effect, or both? Discov Med 2012; 13:451-60.
11. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 2009; 17:118-23.
12. AlcaideML, Parmigiani A, Pallikkuth S, et al. Immune activation in HIVinfected aging women on antiretrovirals-implications for age-associated comorbidities: a cross-sectional pilot study. PLoS One 2013; 8:e63804.
13. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011; 29:621-63.
14. Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. Follicular helper T cells: lineage and location. Immunity 2009; 30:324-35.
15. McHeyzer-WilliamsM, Okitsu S,Wang N,McHeyzer-Williams L.Molecular programming of B cell memory. Nat Rev Immunol 2011; 12:24-34.
16. Oropallo MA, Cerutti A. Germinal center reaction: antigen affinity and presentation explain it all. Trends Immunol 2014; 35:287-9.
17. Boswell KL, Paris R, Boritz E, et al. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog 2014; 10:e1003853.
18. Pallikkuth S, Parmigiani A, Silva SY, et al. Impaired peripheral blood Tfollicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine. Blood 2012; 120:985-93.
19. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 1968; 97:77-89.
20. Hsiung GD, Fong CKY, Landry ML. Hsiung's diagnostic virology: as illustrated by light and electron microscopy. 4th ed. New Haven, CT: Yale University Press, 1994:404.
21. Pallikkuth S, Pilakka Kanthikeel S, Silva SY, Fischl M, Pahwa R, Pahwa S. Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy. J Immunol 2011; 186:6173-81.
22. Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigenspecific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004; 286:111-22.
23. Locci M, Havenar-Daughton C, Landais E, et al. Human circulating PD-(+)1CXCR3(-)CXCR5(+) memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 2013; 39:758-69.
24. MMWR. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2013-2014. http://www.cdc.gov/mmwr.htm. Accessed 20 July 2014.
25. Deeks SG, Verdin E, McCune JM. Immunosenescence and HIV. Curr Opin Immunol 2012; 24:501-6.
26. Cubas RA,MuddJC, Savoye AL, et al. InadequateTfollicular cell help impairs B cell immunity during HIV infection. Nat Med 2013; 19:494-9.
27. Pallikkuth S, Parmigiani A, Pahwa S. Role of IL-21 and IL-21 receptor on B cells in HIV infection. Crit Rev Immunol 2012; 32:173-95.
28. Berglund LJ, Avery DT, Ma CS, et al. IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts. Blood 2013; 122:3940-50.
29. Spensieri F, Borgogni E, Zedda L, et al. Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses. Proc Natl Acad Sci U S A 2013; 110:14330-5.
30. Choi YS, Kageyama R, Eto D, et al. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 2011; 34:932-46.
31. Bauquet AT, Jin H, Paterson AM, et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat Immunol 2009; 10:167-75.
32. Schmitt N, Morita R, Bourdery L, et al. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 2009; 31:158-69.
33. Perkey E, Miller RA, Garcia GG. Ex vivo enzymatic treatment of aged CD4 T cells restores cognate T cell helper function and enhances antibody production in mice. J Immunol 2012; 189:5582-9.
34. Yu M, Li G, Lee WW, et al. Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age. Proc Natl Acad Sci U S A 2012; 109:E879-88.
35. Lefebvre JS, Haynes L. Vaccine strategies to enhance immune responses in the aged. Curr Opin Immunol 2013; 25:523-8.
36. ZhangW, Brahmakshatriya V, Swain SL. CD4 T cell defects in the aged: causes, consequences and strategies to circumvent. Exp Gerontol 2014; 54:67-70.
37. Herati RS, Reuter MA, Dolfi DV, et al. Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults. J Immunol 2014; 193:3528-37.
38. Schmitt N, Bentebibel SE, Ueno H. Phenotype and functions of memory Tfh cells in human blood. Trends Immunol 2014; 35:436-42.
39. Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity 2013; 39:633-45.
40. Frasca D, Romero M, Diaz A, et al. A molecular mechanism for TNFalpha-mediated downregulation of B cell responses. J Immunol 2012; 188:279-86.
41. Cope AP, Liblau RS, Yang XD, et al. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 1997; 185:1573-84.
42. Isomaki P, Panesar M, Annenkov A, et al. Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface. J Immunol 2001; 166:5495-507.
43. Bose F, Raeli L, Garutti C, et al. Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues. Clin Immunol 2011; 139:164-76.
44. Naugler WE, Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 2008; 14:109-19.
45. Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 2006; 61:575-84.
46. Center for Disease Control and Prevention. Fluzone high-dose seasonal influenza vaccine. http://www.cdc.gov/flu/protect/vaccine/qa-fluzone. htm. Accessed 20 November 2014.
47. DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014; 371:635-45.